Citius Pharmaceuticals (CTXR) Net Shares Issued and Repurchased (2014 - 2025)

Citius Pharmaceuticals (CTXR) has reported Net Shares Issued and Repurchased for 11 consecutive years, with $2134.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased fell 98.85% year-over-year to $2134.0; the trailing twelve-month figure through Dec 2025 stood at $2134.0 (down 98.85% YoY), and the FY2025 full-year result was $5.8 million, up 3355.53% from the prior year.
• Net Shares Issued and Repurchased slipped to $2134.0 in Q4 2025 per CTXR's latest filing, from $5.8 million in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $5.8 million in Q3 2025 and bottomed at $2134.0 in Q4 2025.
• Historically, Net Shares Issued and Repurchased has averaged $2.8 million across 5 years, with a median of $3.6 million in 2022.
• The widest YoY moves for Net Shares Issued and Repurchased: up 3355.53% in 2025, down 98.85% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $3.3 million in 2021, then advanced by 17.92% to $3.8 million in 2022, then grew by 6.1% to $4.1 million in 2023, then slumped by 95.47% to $185000.0 in 2024, then tumbled by 98.85% to $2134.0 in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2134.0, $5.8 million, and $185000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.